BioCentury
ARTICLE | Clinical News

Oncolym 131-Iodine/LYM-1: TCLN's Alpha Therapeutic Corp. to begin a Phase III trial

March 7, 1994 8:00 AM UTC

Techniclone International Corp. (TCLN) Tustin, Calif. Product: Oncolym 131-Iodine/LYM-1 monoclonal antibody Indication: Non-Hodgkin's lymphoma Status: TCLN's Alpha Therapeutic Corp., subsidiary filed...